AUSTRALIA'S #1 ONLINE CPD EDUCATION PLATFORM

Education

Gain a succinct overview of specific topics relating to every day practice with our 1, 2 or 6 hour education modules; quick and easy to complete anytime, anywhere. You will receive a certificate for completing any of these education activities. CPD points are also available. Our ALMs provide the opportunity to develop indepth knowledge, skills, behaviour and attitudes in a range of therapeutic areas.

Strong Steps program: Stepwise approach to identification and prevention of osteoporotic fracture

By 2022, it is estimated that 6.2 million Australians older than 50 years of age will have osteoporosis or osteopenia, placing them at high risk of minimal trauma fracture. This program aims to support identification, evaluation and treatment of patients at high risk of osteoporotic fracture.

Rethinking first injectable therapies in type 2 diabetes: A practical approach

This accredited learning module explores how to initiate injectable therapy in a patient with type 2 diabetes who remains above their glycaemic target despite taking dual or triple oral therapy. The activity works through 3 in-depth case-studies: a patient with uncomplicated T2D, a patient with ASCVD risk, and a patient with established ASCVD.

T2D injectables: 1. Intensifying to first injectable therapy in uncomplicated type 2 diabetes

This education module focuses on a case study of an uncomplicated patient with type 2 diabetes, and the process of intensifying to first injectable therapy. Expert video commentary throughout the module helps step the participant through the decision cycle from the ADA/EASD consensus guidelines for T2D. This module also includes Australian recommendations for patients fasting during Ramadan.

T2D injectables: 2. Intensifying to first injectable therapy in patients with ASCVD risk

In this education module, the participant will work through a case study of a type 2 diabetes patient with ASCVD risk factors. The case study uses the decision cycle from the ADA/EASD consensus guidelines for T2D, and features expert video commentary. The module also discusses patient-related concerns leading to clinical inertia, including useful management decisions when faced with this issue.

T2D injectables: 3. Intensifying to first injectable therapy in patients with established ASCVD

This education module takes a case-study based look at the management of a type 2 diabetes patient with established ASCVD. Featuring expert video commentary, participants will use the decision cycle from the ADA/EASD consensus guidelines for T2D to work through a hypothetical case study. This module also discusses GP-related causes of clinical inertia, as well as additional patient factors such as obesity, low health literacy and diabetes distress.

Live webinar - Finding a good fit: A patient-centred approach to antidepressant treatment - 10 February 2021

7:00pm - 8:30pm AEDT | RACGP: 3pts | ACRRM: 2hrs This case-based webinar will explore a more patient-centric management of depression, giving you an opportunity to update your skills in tailoring depression treatment to patient symptoms. In the context of overall management, a focus will be enhancing efficacy of antidepressant treatment while minimising side effects, and initiatives to improve adherence, in order to increase the likelihood of treatment success.

Pages